ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,073.16
-0.84%
Dow Jones
38,020.07
-0.95%
US Dollar vs MXN
17.1122
0.58%
Brent Oil
86.455
-0.95%
Bitcoin
60,367.37
-5.44%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. INVO BioScience Inc (INVO)

  7. INVO BioScience Inc (INVO) Noticias

INVO INVO BioScience Inc

1.0004
-0.0596 (-5.62%)
Última actualización: 12:51:16
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
INVO BioScience Inc INVO NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.0596 -5.62% 1.0004 12:51:16
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.05 1.00 1.08 1.06
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
17/4/202409:25APSMicro Cap Massively Bid Up Before Opening Bell
16/4/202415:59GLOBEINVO Reports Fourth Quarter and Full Year 2023 Financial..
06/2/202409:24EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202408:01EDGAR2Form 8-K - Current report
23/1/202407:00GLOBENAYA Biosciences To Acquire Clinical Stage Gene Therapy..
17/1/202407:00GLOBEINVO Bioscience Files S-4 Registration and Preliminary Joint..
16/1/202416:29EDGAR2Form S-4 - Registration of securities, business combinations
10/1/202415:46EDGAR2Form 8-K/A - Current report: [Amend]
10/1/202415:05EDGAR2Form 8-K - Current report
03/1/202416:29EDGAR2Form 8-K - Current report
28/12/202316:04EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
28/12/202316:02EDGAR2Form 8-K - Current report
13/12/202316:08EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
13/12/202315:53EDGAR2Form 8-K - Current report
11/12/202307:00PRNUSNAYA Biosciences Announces Publication of New Data for its..
28/11/202316:18EDGAR2Form 8-K - Current report
28/11/202308:00PRNUSINVO Bioscience Regains Compliance with Nasdaq Minimum..
24/11/202312:08EDGAR2Form DEF 14A - Other definitive proxy statements
20/11/202315:59EDGAR2Form 8-K - Current report
13/11/202315:10EDGAR2Form 8-K - Current report
13/11/202315:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202315:01PRNUSINVO Reports Record Third Quarter 2023 Financial Results
13/11/202308:23EDGAR2Form SC TO-C - Written communication relating to an issuer..
13/11/202308:21EDGAR2Form 8-K - Current report
13/11/202308:12EDGAR2Form PRE 14A - Other preliminary proxy statements
10/11/202308:00PRNUSNAYA Biosciences and INVO Bioscience Announce Appointment of..
09/11/202315:40PRNUSINVO Bioscience Announces Commencement of Waiver..
27/10/202308:00PRNUSFree Registration Is Now Open For Tribe Public's CEO and Q&A..
26/10/202315:56EDGAR2Form 8-K - Current report
24/10/202316:10EDGAR2Form 8-K - Current report
23/10/202306:30PRNUSINVO Bioscience and NAYA Biosciences Announce Definitive..
16/10/202305:15EDGAR2Form 8-K - Current report
11/10/202308:00PRNUSINVO to Participate in the Lytham Partners Fall 2023..
05/10/202315:28EDGAR2Form 8-K - Current report
03/10/202316:24EDGAR2Form 8-K - Current report
02/10/202316:12EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/9/202316:26EDGAR2Form 8-K - Current report
29/9/202315:05PRNUSINVO BIOSCIENCE ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF..
28/9/202311:45EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
28/9/202311:30PRNUSINVO Reminds Shareholders to Cast Their Vote for Upcoming..
08/9/202315:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/9/202316:17EDGAR2Form 8-K - Current report
01/9/202308:55EDGAR2Form DEF 14A - Other definitive proxy statements
21/8/202315:33EDGAR2Form PRE 14A - Other preliminary proxy statements
14/8/202315:10EDGAR2Form 8-K - Current report
14/8/202315:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202315:05PRNUSINVO Reports Second Quarter 2023 Financial Results
11/8/202315:18EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/8/202313:07EDGAR2Form 8-K - Current report
11/8/202307:00PRNUSINVO Closes Acquisition of Wisconsin Fertility Institute

Su Consulta Reciente

NASDAQ
INVO
INVO BioScience
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados